Ataxic Guillain–Barré syndrome with anti-GQIb antibody: Relation to Miller Fisher syndrome
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
I have followed Yuki et al.’s work on Miller Fisher syndrome (MFS) and its variants for some time.1 I believe the authors are mistaken on the following points: 1) making any distinction between Fisher and Bickerstaff syndromes2,3⇓; and 2) ignoring cardinal signs of CNS involvement in Fisher and Guillain–Barré syndromes such as ballism (first described by Dr. Yuki himself), opsoclonus, myoclonus, Babinski sign, internuclear ophthalmoplegia, and, in this case, cerebellar ataxia. I believe these mistakes are rooted in blindly following authority, lacking a historical perspective on the issue,1 and an unfounded belief that a normal conventional MRI means absence of a CNS lesion. On the issues of ignoring cardinal signs of CNS involvement and following “certain well established ideas” on Guillain–Barré they are in the company of no less a luminary than Fisher himself, with a major distinction: Yuki et al. are living in the wonderful age of computerized neuroimaging.1 A normal conventional MRI means nothing in this context for the following reasons: …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathiesK. Kimoto, M. Koga, M. Odaka et al.Neurology, November 27, 2006 -
Articles
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndromeMolecular mimicry and host susceptibilityK. A. Sheikh, I. Nachamkin, T. W. Ho et al.Neurology, August 01, 1998 -
Articles
Treatment of Guillain-Barré Syndrome with Intravenous ImmunoglobulinRichard A. Sater, Abdolmohamad Rostami et al.Neurology, December 01, 1998 -
Article
Current treatment practice of Guillain-Barré syndromeChristine Verboon, Alex Y. Doets, Giuliana Galassi et al.Neurology, June 07, 2019